Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study

scientific article published on 04 March 2020

Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S43044-020-00045-5
P932PMC publication ID7056751
P698PubMed publication ID32130547

P50authorGhada YoussefQ87822218
P2093author name stringMagdy Abdel Hamid
Ahmed El-Gengehe
Amr Abdel Aal
Sherif Nagy
P2860cites workGlobal burden of hypertension: analysis of worldwide dataQ28302545
Efficacy and safety of nighttime dosing of antihypertensives: review of the literature and design of a pragmatic clinical trial.Q33881994
Benefits of once-daily therapies in the treatment of hypertensionQ35660819
Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC studyQ45204771
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart AssociationQ49546493
Validation of the Omron MX3 Plus oscillometric blood pressure monitoring device according to the European Society of Hypertension international protocol.Q51450610
Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen.Q53916488
European Society of Hypertension Position Paper on Ambulatory Blood Pressure MonitoringQ57085349
Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting MortalityQ57085545
Adherence: Comparison of Methods to Assess Medication Adherence and Classify NonadherenceQ57461210
Randomized Crossover Trial of the Impact of Morning or Evening Dosing of Antihypertensive Agents on 24-Hour Ambulatory Blood PressureQ57819116
Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressureQ61456659
FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug AdministrationQ71873159
Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurementsQ73484498
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjectsQ77704953
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]Q90299617
Masked uncontrolled hypertension: Prevalence and predictorsQ90785895
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy TrialQ90891501
P433issue1
P304page(s)9
P577publication date2020-03-04
P1433published inEgyptian Heart JournalQ50497729
P1476titleOnce versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study
P478volume72

Search more.